ZabBio develops monoclonal antibody-based products for infectious diseases and reproductive health.
Members of ZabBio’s core development team have worked together on antibody discovery, engineering, and manufacture.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
For prior clinical trials of MB66 and ZB06, ZabBio scientists undertook drug manufacture, nonclinical study design, regulatory filings, and Phase 1 trial planning and oversight.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
Open the published source list.RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 3, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 6, 2026, September 14, 2026, September 15, 2026, September 23, 2026, September 29, 2026, October 7, 2026 and October 10, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.